COIL · Coiled Therapeutics PLC · Financials
Market Cap
32.01M GBP
Shares
426.79M
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Browse captured authority reports and their original financial labels
Revenue
0
-100%
FY2024
Net Income
-971.8K
+44.3%
FY2024
Gross Margin
100%
FY2023
Operating Cash Flow
-783.73K
+54.8%
FY2024
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2024 | FY2023 | FY2022 |
|---|---|---|---|
| GBP | 0 | 200K | 0 |
| GBP | 16K | 0 | 0 |
| GBP | 152.92K | 620.16K | 319.32K |
| GBP | 931.64K | 1.5M | 1.31M |
| GBP | 5404 | 3890 | 0 |
| GBP | 52.79K | 0 | — |
| GBP | -1.21M | -1.93M | -1.63M |
| GBP | -242.77K | -187.69K | -18.89K |
| GBP | -971.8K | -1.74M | -1.62M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Short-term borrowings | 2024-12-31 | GBP 400,092 | ESEF Annual Report filed 2025-05-20 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.